Advertisement

Oral Insulin Conditionally Approved by FDA

Updated

The U.S. Food and Drug Administration (FDA) has approved Oral-lyn, an insulin spray for people with Type 1 and Type 2 diabetes, for its Treatment Investigational New Drug (IND) program. This approval will allow Generex Biotechnology Corporation, developers of Oral-lyn, to provide early access to the medicine to people with serious or life-threatening Type 1 or Type 2 diabetes who have no satisfactory alternative treatments and who are not eligible for participation in the company’s ongoing Phase III clinical trial of the drug… Read More “Oral Insulin Conditionally Approved by FDA”

Syringe Recall; Mediterranean Diet May Delay Need for Drugs

Updated

Qualitest Pharmaceuticals has voluntarily issued a nationwide recall of Accusure Insulin Syringes due to the possibility of the needles detaching from the syringes. Were such detachment to occur while a syringe was being used, it could cause the needle to become stuck in an insulin vial, to push back into the barrel, or to remain in the skin after an injection… Read More “Syringe Recall; Mediterranean Diet May Delay Need for Drugs”

 

The latest delivered straight to your inbox

Learn More

Newsletter

Subscribe to Stay Informed

Sign up for Free

Get the latest diabetes news and a free gift!

Learn More

Save Your Favorites